drugs

According to the statement, "The recommendation to terminate was made based upon both the observation that V710 was unlikely to demonstrate a statistically significant clinical benefit as well as a safety concern regarding overall

Merck (NYSE:MRK) and Intercell AG announced today that, following a recommendation by the Data Monitoring Committee, the companies are terminating the Phase II/III Clinical trial for their V710 vaccine.

The system is widely used in hospitals, emergency rooms, and physicians' offices, allowing real-time diagnostic results to be transmitted from the patient bedside.

Greg Arnsdorff, head of Abbott's point of care business said, "With i-STAT 1 Wireless, caregivers are able to share critical test information electronically without leaving the patient's bedside, By empowering nurses to sta

Abbott (NYSE:ABT) announced today it has received clearance from the Food and Drug Administration to begin marketing the i-STAT 1 Wireless handheld, a new version of the i-STAT point of care testing system.

Sangamo BioSciences (SGMO) is up after it says data from its programs to develop ZFN-based therapeutic approaches for the treatment of HIV/AIDS were discussed in four oral presentations at the 18th Conference on Retroviruses and O

Well operations were suspended in June 2010 as a result of the deep-water Gulf of Mexico drilling moratorium. Santiago is a middle Miocene amplitude prospect
on Mississippi Canyon Block 519. Noble Energy is the operator with

Located in 6,500 feet of water, the Santiago exploration well had previously
drilled to a depth of 13,585 feet at the time of the moratorium.

Noble Energy is down 1.23% to $91.52 after the company late Monday received a permit to resume drilling at the Santiago prospect in the deep-water Gulf of Mexico.

The trial found patients taking the drug experienced a 17% relative improvement in their ability to force air out of their lungs in one second, a common measure of success in treating lung disease, compared with those on a placebo

Vertex's trial would have been deemed a success if it had delivered just a 4.5% improvement in the lung function test.

Shares of Vertex Pharmaceuticals (NASDAQ:VRTX) are up over 14% today, after it announced positive clinical trial results for its cystic fibrosis fighting drug VX-770.

Gilead Sciences (GILD) today announced that it has acquired Calistoga Pharmaceuticals, a privately held company, for $375 million. GILD stated that with the acquisition, it hopes to expand its research capabilities into cancer dru

The dispute arose when ABT said it was reluctant to launch and commercialize DM-1796, an investigational, once-daily formulation of gabapentin for the management of post-herpetic neuralgia.

Shares of DepoMed (DEPO) dropped as much as 13.37% to $5.70 in pre-market trading as the company tries to resolve its ongoing dispute with Abbott Laboratories (ABT) over the commercialization of its investigational drug DM-1796. T

The judge rejected Teva's arguments that Amgen's patents were invalid.

Amgen shares are up 0.74%, or $0.42, to $56.97.

Shares of Amgen (AMGN) are higher after the drug maker won a ruling in a U.S. court that blocks generic drugmaker Teva Pharmaceuticals (TEVA) from selling a generic version of its kidney drug Sensipar until--at a minimum--2016, Bl

Citigroup Inc. adjusted its 2011 and 2012 EPS estimates for Walgreen Co. (NYSE:WG) on Thursday, but maintained the firm's $31.00 price target and Sell rating. Citigroup lifted its 2011 EPS estimate for the firm from $2.41 to $2.44